DekaBank Deutsche Girozentrale
ELOS

DekaBank Deutsche Girozentrale’s Syneron Medical Ltd ELOS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-30,000
Closed -$371K – 1197
2015
Q1 		$371K Buy
+30,000
New +$332K ﹤0.01% 785

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ELOS Position: Q2 2015 in Review

DekaBank Deutsche Girozentrale sold out of Syneron Medical Ltd (ELOS) in Q2 2015, closing a stake of 30,000 shares — an estimated $371K sold.

DekaBank Deutsche Girozentrale first reported a position in ELOS in Q1 2015 and held it in 1 quarter. The position peaked at $371K in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2015.

  • DekaBank Deutsche Girozentrale reported no remaining Syneron Medical Ltd position as of Q2 2015 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 30,000 Syneron Medical Ltd shares in Q2 2015, an estimated $371K.
  • DekaBank Deutsche Girozentrale first reported a position in Syneron Medical Ltd in Q1 2015 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Syneron Medical Ltd position peaked at $371K in Q1 2015.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2015, filed 13 Aug 2015.